Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  9,501 results for ""Antigens, CD19""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

C-CAR066, a novel fully human anti-CD20 CAR-T therapy for relapsed or refractory large B-cell lymphoma after failure of anti-CD19 CAR-T therapy: A phase I clinical study.

  • Authors : Li P; Tongji Hospital of Tongji University, Shanghai, China.; Liu W

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/therapy

  • Source: American journal of hematology [Am J Hematol] 2024 Dec; Vol. 99 (12), pp. 2306-2312. Date of Electronic Publication: 2024 Oct 01.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CD19 + CD73 + B cells infiltration indicates poor prognosis and unfavorable responses to immunotherapy in gastric cancer.

  • Authors : Zhang Y; Department of Gastrointestinal Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Wang W

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/immunology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Nov 15; Vol. 141, pp. 113002. Date of Electronic Publication: 2024 Aug 29.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer: A Nonrandomized Clinical Trial.

  • Authors : Chen N; Cancer Center, the First Hospital of Jilin University, Changchun, China.; Pu C

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/therapy ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/immunology

  • Source: JAMA oncology [JAMA Oncol] 2024 Nov 01; Vol. 10 (11), pp. 1532-1536.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma.

  • Authors : Pophali PA; Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin, Carbone Cancer Center, Madison, WI.; Fein JA

Subjects: Antigens, CD19*/Antigens, CD19*/Antigens, CD19*/immunology ; Antigens, CD19*/Antigens, CD19*/Antigens, CD19*/therapeutic use ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/therapy

  • Source: Blood advances [Blood Adv] 2024 Oct 22; Vol. 8 (20), pp. 5290-5296.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.

Subjects: Biological Products*/Biological Products*/Biological Products*/therapeutic use ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/therapy ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/mortality

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 20; Vol. 42 (30), pp. 3581-3592. Date of Electronic Publication: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

CD9 and Aryl Hydrocarbon Receptor Are Markers of Human CD19+CD14+ Atypical B Cells and Are Dysregulated in Systemic Lupus Erythematous Disease.

  • Authors : Blevins LK; Institute of Integrative Toxicology, Michigan State University, East Lansing, MI.; Khan DMIO

Subjects: Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/immunology ; Receptors, Aryl Hydrocarbon*/Receptors, Aryl Hydrocarbon*/Receptors, Aryl Hydrocarbon*/genetics ; Receptors, Aryl Hydrocarbon*/Receptors, Aryl Hydrocarbon*/Receptors, Aryl Hydrocarbon*/metabolism

  • Source: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2024 Oct 15; Vol. 213 (8), pp. 1076-1092.Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

CD19: a promising target for systemic sclerosis.

  • Authors : Komura K; Department of Dermatology, Kanazawa Red Cross Hospital, Japanese Red Cross Society, Kanazawa, Ishikawa, Japan.

Subjects: Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/immunology ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/drug therapy ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/therapy

  • Source: Frontiers in immunology [Front Immunol] 2024 Oct 03; Vol. 15, pp. 1454913. Date of Electronic Publication: 2024 Oct 03 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Identifying CD19-targeted CAR-T cell immune pathways in an in vitro human immune mimetic cytokine release assay.

Subjects: Antigens, CD19*/Antigens, CD19*/Antigens, CD19*/immunology ; Antigens, CD19*/Antigens, CD19*/Antigens, CD19*/metabolism ; Cytokines*/Cytokines*/Cytokines*/metabolism

  • Source: Journal of immunotoxicology [J Immunotoxicol] 2024 Oct; Vol. 21 (sup1), pp. S29-S37. Date of Electronic Publication: 2024 Dec 10.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101201960 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma.

  • Authors : Khaliq A; Department of Medicine, University of Kansas School of Medicine, Kansas City, KS.; Wesson W

Subjects: Authorship* ; Lymphoma*/Lymphoma*/Lymphoma*/therapy ; Antigens, CD19*/Antigens, CD19*/Antigens, CD19*/immunology

  • Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Oct; Vol. 24 (10), pp. e344-e349. Date of Electronic Publication: 2024 May 31.Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

PD1 + CD4 + T cells promote receptor editing and suppress autoreactivity of CD19 + CD21 low B cells within the lower respiratory airways in adenovirus pneumonia.

  • Authors : Lu B; Department of Respiratory Medicine, State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Medical University, Guangzhou, Guangdong 510623, China; Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China.

Subjects: Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/metabolism ; B-Lymphocytes*/B-Lymphocytes*/B-Lymphocytes*/immunology ; B-Lymphocytes*/B-Lymphocytes*/B-Lymphocytes*/metabolism

  • Source: Mucosal immunology [Mucosal Immunol] 2024 Oct; Vol. 17 (5), pp. 1045-1059. Date of Electronic Publication: 2024 Jul 20.Publisher: Elsevier Country of Publication: United States NLM ID: 101299742 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  9,501 results for ""Antigens, CD19""